Prescription rates of the contraceptive implant in Australia 2008–2012: impact of patient age and area of residence

Sexual Health ◽  
2016 ◽  
Vol 13 (1) ◽  
pp. 87 ◽  
Author(s):  
Amie L. Bingham ◽  
Cameryn C. Garrett ◽  
Anne M. Kavanagh ◽  
Louise A. Keogh ◽  
Rebecca J. Bentley ◽  
...  
Keyword(s):  
Family Planning ◽  
Associated Factors ◽  
Effective Means ◽  
Geographic Location ◽  
Negative Consequences ◽  
Patient Age ◽  
Patient Âgé ◽  
Prescription Rates ◽  
Long Acting ◽  
Long Acting Reversible Contraceptives

Background Long-acting reversible contraceptives are an effective means of preventing unwanted pregnancies and associated negative consequences. The Sexual Health and Family Planning Association of Australia has called for efforts to address barriers to the uptake of long-acting reversible contraceptives (LARCs) in Australia, where LARC uptake is thought to be low, though comprehensive data describing use and associated factors is scarce. The aims of this study were to describe patterns of prescriptions for the etonogestrel-releasing subdermal implant (SDI) in Australia, 2008–2012, and associated factors. Methods: Records of prescriptions written through Australia’s Pharmaceutical Benefits Scheme from 2008 to 2012 were obtained, including patient age and geographic location. Direct, age-standardised rates (ASR) of prescriptions were calculated for each year and location, with multivariate analysis used to examine associations between prescription rates and patient age, location and proximity to family planning clinics (FPC) or Aboriginal Medical Services (AMS). Results: ASR of prescriptions rose ~6% per year (OR 1.06, 95%CI: 1.05–1.06) from 13.05 per 1000 (2008) to 15.76 per 1000 (2012; P < 0.01). Rates were highest among 15- to 19-year-olds, increasing from 20.81 (2008) to 29.09 per 1000 (2012: P < 0.01) and lowest among 45- to 49-year-olds, increasing from 3.37 to 3.73 per 1000 (P < 0.01). ASR by location were significantly higher in regional than metropolitan areas. Conclusions:This is the first analysis of SDI prescriptions across all ages and regions of Australia. Uptake of SDI in Australia is increasing but remains low. Significant associations were found between prescription rates and patient age and residence in regional/remote areas.

scholarly journals Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

2003 ◽  
Vol 41 (5) ◽  
pp. 2176-2179 ◽  
Author(s):  
M. A. Pfaller ◽  
S. A. Messer ◽  
L. Boyken ◽  
S. Tendolkar ◽  
R. J. Hollis ◽  
...  
Keyword(s):  
Candida Glabrata ◽  
Geographic Location ◽  
Patient Age ◽  
Patient Âgé

scholarly journals The Utilization of Long-Acting Reversible Contraception and Associated Factors Among Women in Indonesia

2020 ◽  
Vol 12 (3) ◽  
pp. 110
Author(s):  
Maria Gayatri
Keyword(s):  
Older Women ◽  
Associated Factors ◽  
Descriptive Analysis ◽  
Working Women ◽  
Reproductive Age ◽  
Modern Contraceptive ◽  
Chi Square ◽  
Long Acting ◽  
Complex Sample Design ◽  
Long Acting Reversible Contraceptives

Long-acting reversible contraceptives (LARCs), consist of IUD and implats, were effective and efficient methods in preventing the pregnancy. However, the used of these methods in Indonesia was still low. This study sought to explore LARC utilization trends and the factors influencing LARC used among reproductive women in Indonesia. This research analyzed data from the Indonesia Demographic and Health Survey 2017. Respondents in this study were women who currently used modern contraceptive methods. A total of 20,409 women who used modern methods were included in the analysis. Descriptive analysis was performed using chi-square and percentages. Logistic regression with complex sample design was used to determine the associated factors in LARC utilization. Among women in reproductive age who currently used modern contraception, IUDs and implants were viewed particularly unfavorably which only 16.5% of women used LARC. Findings highlighted that higher LARC use among reproductive age women in Indonesia correlated with higher parity, older women, higher education, working women, desire to limit the pregnancy in the future and more visited by fieldworkers in the last 12 months. This study underscored that even though only 4% of respondents were visited by fieldworkers, the utilize of LARC was higher among women who visited by fieldworkers. This study suggests that communication skills among fieldworker need to be enhanced to do counselling and work closely with the community member.

scholarly journals Effectiveness of task-sharing in providing comprehensive long-acting reversible contraceptives through Level IV health extension workers in rural Ethiopia

2021 ◽  
Author(s):  
Alula Teklu ◽  
Awol Seid ◽  
Kassahun Mormu ◽  
Tesfa Demlew ◽  
Ephrem Tekle ◽  
...  
Keyword(s):  
Family Planning ◽  
Health Extension Workers ◽  
Chi Square ◽  
New Family ◽  
Positive Attitudes ◽  
Desire To Have Children ◽  
Modern Family ◽  
Planning Methods ◽  
Long Acting ◽  
Long Acting Reversible Contraceptives

Abstract Background: Modern family planning uptake in Ethiopia, primarily short-acting injectables, has increased after the engagement of community health extension workers (HEWs). The aim of this study was to investigate the effectiveness of using Level IV health extension workers to deliver long-acting reversible contraceptives (LARCs) at the community level. Methods: A retrospective cohort study design was used to recruit 710 women who received LARC insertion services at pilot health posts within eight months before survey time. The interviewer administered a data collection tool to collect the required data through a house-to-house survey. The questionnaire had sections covering demographic and socioeconomic characteristics, reproductive history, use of family planning methods, knowledge about LARC methods (i.e., IUCD and Implanon), and service satisfaction. Descriptive statistics were used to analyze data. Chi-square test was used to identify the determinants of LARC use. Results: Out of 702 LARC users included in the study, 92.7% received services from Level IV HEWs. The median age of clients was 30 years (IQR: 25–35), 92.7% were married, and 22.6% were new family planning users (75% Implanon users and 19.4% Jaddelle users). Of the aggregated variables, 67.38% had good knowledge of LARC, 92.28% had positive attitudes in availing services at health posts, and 92.76% was the satisfaction score of clients. New users tended to be young, Muslim, less likely to want more children, and more likely to decide on contraception on their own. At eight months post insertion, LARC use was effective in preventing pregnancy (99.7%) with low removal (n = 36, 5.1%) and expulsion rates (n = 1, 0.1%). No infection was reported. The major reasons for removal were side effects and the desire to have children. Client knowledge, attitude, and satisfaction were found to be high. In conclusion, trained Level IV HEWs provided LARCs safely and effectively at the health post level as an alternative service delivery outlet.

scholarly journals Disparities in Long-Acting Reversible Contraceptive Utilization among Married Women in Ethiopia: Findings of the Ethiopian Demographic and Health Survey

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Biniyam Tadesse Haile ◽  
Yohannes Ejigu Tsehay
Keyword(s):  
Family Planning ◽  
Health Survey ◽  
Associated Factors ◽  
Married Women ◽  
Demographic And Health Survey ◽  
Contraceptive Methods ◽  
Contraceptive Utilization ◽  
Planning Methods ◽  
Long Acting ◽  
Family Planning Methods

Background. Long-acting contraceptive methods, subdermal implants, and intrauterine devices are reliable, safe, and cost-effective family planning methods. However, these methods are not widely used in Ethiopia despite government effort to increase access. The study is aimed at assessing the rate of utilization of long-acting contraceptive methods among married women and associated factors. Method. We analyzed the 2016 Ethiopian Demographic and Health Survey dataset. A total of 2045 married women of reproductive age group, who were using any modern contraceptive method at the time of the survey, were included in the study. Descriptive statistics were computed to characterize the study participants. Bivariate and multivariable logistic regression analyses were performed to identify associated factors, reporting odds ratios (ORs) and 95% confidence intervals (95% CIs). Result. The multivariable analyses showed that women educational status, parity, religion, previous history of abortion, desire for more child, and region where the respondents reside were significantly the factors that determine the utilization of long-acting contraceptive. There is a significant regional disparity in long-acting contraceptive utilization. Compared to women residing in Tigray region, those who live in other regions (Afar-Somali, Oromia, Amhara, Benishangul Gumz-Gambela, and Southern Nations Nationalities and People) have low likelihood of using long-acting contraceptive methods. Conclusion. Utilization of long-acting family planning method is low in Ethiopia. There is a significant regional disparity in utilizing these methods. Policy makers should promote culture-sensitive and tailored interventions to improve the utilization of long-acting family planning methods.

scholarly journals Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes

2020 ◽  
Vol 10 ◽  
pp. 204512532098150
Author(s):  
Katalin Pungor ◽  
Vasilis P. Bozikas ◽  
Robin Emsley ◽  
Pierre-Michel Llorca ◽  
Srihari Gopal ◽  
...  
Keyword(s):  
Disease Duration ◽  
Age Groups ◽  
Paliperidone Palmitate ◽  
Patient Age ◽  
Patient Âgé ◽  
Efficacy Outcome ◽  
Favourable Safety ◽  
Favourable Safety Profile ◽  
Symptomatic Remission ◽  
Long Acting

Background: Paliperidone palmitate 3-monthly (PP3M) is a second-generation, long-acting injectable antipsychotic formulation indicated for the maintenance treatment of adults with schizophrenia first stabilized with paliperidone palmitate 1-monthly (PP1M). This exploratory post hoc subgroup analysis of the 52-week, phase 3b REMISSIO study analysed outcomes according to patient age and disease duration in a naturalistic clinical setting. Methods: Outcomes of patients with schizophrenia were analysed according to age [<35 years ( n = 123) versus ⩾35 years ( n = 182)] and disease duration [⩽3 years ( n = 72) versus >3 years ( n = 233)]. The primary efficacy outcome was the proportion of patients achieving symptomatic remission according to the Andreasen criteria. Adverse events were monitored throughout the study. Results: At endpoint (last observation carried forward), 60.7% (95% CI: 51.4%, 69.4%) of younger patients and 54.1% of older patients (95% CI: 46.6%, 61.6%) achieved symptomatic remission. The proportions for patients with disease duration ⩽3 years and >3 years were similar: 57.8% (45.4%, 69.4%) versus 56.5% (49.8%, 62.9%). Functional remission was reached by 45.4% (36.2%, 54.8%) of patients aged <35 years and 36% (28.9%, 43.6%) of patients aged ⩾35 years with a similar pattern when analysed by disease duration. PP3M had a favourable safety profile and was generally well tolerated in both age groups. Conclusion: Patients with schizophrenia, previously stabilized on PP1M, may benefit from PP3M treatment with some additional potential improvements if started early in the disease course. Clinical trials.gov: NCT02713282

Sign in / Sign up

Export Citation Format

Share Document